Dr. Abou-Alfa on Doxorubicin Plus Sorafenib in Liver Cancer
March 11th 2013Ghassan K. Abou-Alfa, MD, Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, describes a study looking at sorafenib plus doxorubicin compared with doxorubicin alone in patients with advanced hepatocellular carcinoma.
Mark G. Kris, MD, Discusses Emerging Targets and Treatments for Lung Cancer
January 4th 2013Mark G. Kris, MD, offers insight into NSCLC related topics, including emerging therapeutic targets, the optimal application of TKIs, strategies for patients with poor performance status, maintenance therapies, and the treatment pipeline.